Lilly's (LLY) COVID-19 Drug Gets FDA Nod for Emergency Use
Published on February 14, 2022
Lilly's (LLY) new antibody-drug, bebtelovimab is authorized to treat certain non-hospitalized adults and pediatric patients with mild-to-moderate COVID-19 who are at high risk of progressing to severe disease